These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35576641)

  • 1. Are Miller Fisher syndrome and CANDA due to a paranodopathy?
    Vallat JM; Deschamps N; Taithe F; Richard L; Duchesne M; Magy L; Mathis S
    J Neurol Sci; 2022 Jul; 438():120279. PubMed ID: 35576641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism.
    Yuki N; Uncini A
    Muscle Nerve; 2014 May; 49(5):629-35. PubMed ID: 24477718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
    Puma A; Benoit J; Sacconi S; Uncini A
    BMC Neurol; 2018 Jul; 18(1):101. PubMed ID: 30031375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-Mediated Neuropathies.
    Gwathmey KG; Smith AG
    Neurol Clin; 2020 Aug; 38(3):711-735. PubMed ID: 32703478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies.
    Susuki K; Yuki N; Schafer DP; Hirata K; Zhang G; Funakoshi K; Rasband MN
    Exp Neurol; 2012 Jan; 233(1):534-42. PubMed ID: 22178332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
    Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
    Umapathi T; Li Z; Verma K; Yuki N
    Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CANOMAD and other chronic ataxic neuropathies with disialosyl antibodies (CANDA).
    Garcia-Santibanez R; Zaidman CM; Sommerville RB; Lopate G; Weihl CC; Pestronk A; Bucelli RC
    J Neurol; 2018 Jun; 265(6):1402-1409. PubMed ID: 29633012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré Syndrome.
    Kaida K
    Adv Exp Med Biol; 2019; 1190():323-331. PubMed ID: 31760653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
    Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
    J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome.
    Yako K; Kusunoki S; Kanazawa I
    J Neurol Sci; 1999 Oct; 168(2):85-9. PubMed ID: 10526188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve ultrasound in Miller Fisher variant of Guillain-Barré syndrome.
    Décard BF; Fladt J; Axer H; Fischer D; Grimm A
    Muscle Nerve; 2015 Dec; 52(6):1106-10. PubMed ID: 26123539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome.
    Hughes RA; Cornblath DR
    Lancet; 2005 Nov; 366(9497):1653-66. PubMed ID: 16271648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune nodo-paranodopathies of peripheral nerve: the concept is gaining ground.
    Uncini A; Vallat JM
    J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):627-635. PubMed ID: 29248893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of Guillain-Barré syndrome.
    Hughes RA; Hadden RD; Gregson NA; Smith KJ
    J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum.
    Ito M; Matsuno K; Sakumoto Y; Hirata K; Yuki N
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):294-9. PubMed ID: 21252265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies.
    Willison HJ; O'Leary CP; Veitch J; Blumhardt LD; Busby M; Donaghy M; Fuhr P; Ford H; Hahn A; Renaud S; Katifi HA; Ponsford S; Reuber M; Steck A; Sutton I; Schady W; Thomas PK; Thompson AJ; Vallat JM; Winer J
    Brain; 2001 Oct; 124(Pt 10):1968-77. PubMed ID: 11571215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.